Gary Francis Breen

Title: Gary Francis Breen - Innovator in Pharmaceutical Compositions

Introduction

Gary Francis Breen, located in Tonbridge, Great Britain, is an accomplished inventor known for his significant contribution to the field of pharmaceutical compositions. With a patent to his name, he has demonstrated a commitment to innovation in medical therapy, particularly in antibacterial treatments.

Latest Patents

Breen holds a patent titled "Process Salts Compositions and Use." This invention provides a novel process for preparing pleuromutilin derivatives and novel salts of mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-ylsulfanyl)-acetate or solvates thereof. His patent also covers innovative pharmaceutical compositions or formulations for topical administration, focusing on the use of mutilin compounds in medical therapy, especially for antibacterial applications.

Career Highlights

Currently, Gary Francis Breen is associated with Glaxo Group Limited, a prominent player in the pharmaceutical industry. His work reflects his dedication to advancing healthcare through innovative solutions and effective treatments.

Collaborations

Throughout his career, Breen has collaborated with notable colleagues, including Michael Anthony Forth and Susan ShuMei Hu Kopelman. These collaborations have likely enriched his research and contributed to the development of his innovative patent.

Conclusion

Gary Francis Breen represents a significant figure in the realm of pharmaceuticals, with his innovations paving the way for advancements in antibacterial therapies. His patent reflects not only his inventiveness but also his commitment to improving medical outcomes through scientific research and collaboration. As he continues his work with Glaxo Group Limited, the future looks promising for further innovations stemming from his expertise.